Stoyanova Lab
  • Home
  • Research
  • Our Group
  • Alumni
  • Publications
  • News
  • Join Our Team
  • Donate
    • Sponsors
  • Contact
Stoyanova Lab
  • Home
  • Research
  • Our Group
  • Alumni
  • Publications
  • News
  • Join Our Team
  • Donate
    • Sponsors
  • Contact

Discussion of the emergence and therapeutic potential for neuroendocrine prostate cancer

May 18, 2022
Dr. Shiqin Liu

The Stoyanova Lab discusses the molecular mechanisms that underly development of neuroendocrine phenotypes in prostate cancer. Congrats to Laura and the team!

https://pubmed.ncbi.nlm.nih.gov/35597438/

May 18, 2022

NewsStanford

FacebookXPinterestRedditDeliciousWhatsappEmail
  • PreviousDiscovery of SU086 as an inhibitor of glycolysis and a potential treatment strategy for advanced prostate cancer

  • NextDiscovery of a new metastasis model to assess the role of notch signaling in prostate cancer

Related Posts ...

Exciting news: Dr. Hyeonji Hwang, a postdoctoral fellow at Dr. Stoyanova’s Lab in UCLA, awarded the Prostate Cancer Research Program Early Investigator Research Award by the US Department of Defense (DOD) for the project titled “Targeting Trop2-Mediated Ferroptosis as a New Therapy for Advanced Prostate Cancer”

News, UCLA

Exciting News: Dr. Tanya Stoyanova receives 2025 Neuroendocrine Tumor Research Foundation Pilot Award

News, UCLA

Logo

ADDRESS

Los Angeles
CA 90095, USA
tstoyanova@mednet.ucla.edu

+1 (310) 825 0955

QUICK LINKS

  • UCLA
  • UCLA Health
  • Positions Available
© Stoyanova Lab. All Rights Reserved. | admin login